On ECHEMI
Home > Drugs > Ebe Pharmaceutical Co., Ltd.
Ebe Pharmaceutical Co., Ltd.
  • Founded in:

    2003-12-18
  • Country:

    China China
  • Address:

    No. 28, High-tech Industrial Park, Wuhan Economic and Technological Development Zone
  • Tax NO.:

    91420000757010980Y
  • Registered Funds:

    114 million yuan
  • Website:

  • Email:

Related Drugs
Neomycin Sulfate Eye Drops
Neomycin sulfate.
Name Description Content CAS NO. Registered Holders
Neomycin sulfate

Neomycin is an aminoglycoside antibiotic. This product has a good effect on Staphylococcus (methicillin-sensitive strains) and Corynebacterium, and also has a good effect on Enterobacteriaceae such as Escherichia coli, Klebsiella, and Proteus. It has poor activity against various groups of Streptococci, Streptococcus pneumoniae, and Enterococci. Pseudomonas aeruginosa and anaerobic bacteria are resistant to this product. Bacteria have partial or complete cross-resistance to streptomycin, neomycin, kanamycin, and gentamicin.

More

Neomycin is an aminoglycoside antibiotic. This product has a good effect on Staphylococcus (methicillin-sensitive strains) and Corynebacterium, and also has a good effect on Enterobacteriaceae such as Escherichia coli, Klebsiella, and Proteus. It has poor activity against various groups of Streptococci, Streptococcus pneumoniae, and Enterococci. Pseudomonas aeruginosa and anaerobic bacteria are resistant to this product. Bacteria have partial or complete cross-resistance to streptomycin, neomycin, kanamycin, and gentamicin.

1405-10-3 11
Pirenoxine sodium eye drops
Main ingredient: Sodium pyrenoxine Chemical name: 1-hydroxy-5-oxo-5H-pyrido-[3,2-?]-phenoxazine-3-carboxylic acid; molecular formula and molecular weight: C16H18N2O5, 308.25.
Name Description Content CAS NO. Registered Holders
1-HYDROXY-5-OXO-5H-PYRIDO[3,2-A]PHENOXAZINE-3-CARBOXYLIC ACID MONOSODIUM SALT

Pirenoxine sodium can competitively inhibit the effects of quinone substances on lens soluble proteins, and can also counteract the damage of free radicals to the lens, thus having a certain inhibitory effect on the development of cataracts; animal experiments have shown that pirenoxine sodium can reduce the incidence of posterior capsule opacity after extracapsular cataract extraction.

More

Pirenoxine sodium can competitively inhibit the effects of quinone substances on lens soluble proteins, and can also counteract the damage of free radicals to the lens, thus having a certain inhibitory effect on the development of cataracts; animal experiments have shown that pirenoxine sodium can reduce the incidence of posterior capsule opacity after extracapsular cataract extraction.

51410-30-1 6
White inner stop
Main ingredient: Sodium pyrenoxine. Chemical name: 1-hydroxy-5-oxo-5H-pyrido-[3,2-a]-phenoxazine-3-carboxylic acid; Chemical structure: Molecular formula: C16H18N2O5 Molecular weight: 308.25
Name Description Content CAS NO. Registered Holders
1-HYDROXY-5-OXO-5H-PYRIDO[3,2-A]PHENOXAZINE-3-CARBOXYLIC ACID MONOSODIUM SALT

It prevents or reduces lens opacity by maintaining and improving the function of the lens membrane and preventing the accumulation of polysaccharide alcohols.

More

It prevents or reduces lens opacity by maintaining and improving the function of the lens membrane and preventing the accumulation of polysaccharide alcohols.

51410-30-1 6
Ciprofloxacin Lactate Eye Drops
Ciprofloxacin lactate, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7(1-piperazinyl)-3-quinolinecarboxylic acid lactate.
Name Description Content CAS NO. Registered Holders
Ciprofloxacin lactate

It has a broad-spectrum antibacterial effect, especially against aerobic Gram-negative bacteria. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

It has a broad-spectrum antibacterial effect, especially against aerobic Gram-negative bacteria. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

97867-33-9 13
Ciprofloxacin lactate

It has a broad-spectrum antibacterial effect, especially against aerobic Gram-negative bacteria. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

It has a broad-spectrum antibacterial effect, especially against aerobic Gram-negative bacteria. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

97867-33-9 13
Compound zinc sulfate eye drops
This product is a compound preparation, its main ingredients are: 1 mg of berberine hydrochloride, 3 mg of zinc sulfate, and 20 mg of boric acid per milliliter.
Name Description Content CAS NO. Registered Holders
Berberine hydrochloride

This product has antibacterial effects and can form complexes with bacterial DNA, thereby affecting DNA replication and interfering with bacterial growth and reproduction; it has inhibitory effects on Gram-positive and Gram-negative bacteria; and can enhance the phagocytic function of human white blood cells.

More

This product has antibacterial effects and can form complexes with bacterial DNA, thereby affecting DNA replication and interfering with bacterial growth and reproduction; it has inhibitory effects on Gram-positive and Gram-negative bacteria; and can enhance the phagocytic function of human white blood cells.

1mg 633-65-8 46
Zinc sulphate

This product has anti-inflammatory and astringent effects, has little irritation to eye tissue and is highly safe.

More

This product has anti-inflammatory and astringent effects, has little irritation to eye tissue and is highly safe.

3mg 7733-02-0 10
Orthoboric acid

This product has anti-inflammatory and astringent effects, has little irritation to eye tissue and is highly safe.

More

This product has anti-inflammatory and astringent effects, has little irritation to eye tissue and is highly safe.

20mg 10043-35-3 18
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.